Abrezekimab
Product Specifications
CAS Number
2043952-59-4
Target
Interleukin, IL Receptor
Related Pathways
Immunology/Inflammation
Purity
0.9834
Bioactivity
Abrezekimab (VR 942) is composed of CDP7766, leucine, and trehalose. Abrezekimab is a humanized antibody that targets human IL-13. Abrezekimab inhibits binding to IL-13Rα1 subunit. Abrezekimab can be used to study biological disorders associated with asthma and lung disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041836-ML405 100 µL
SLC22A6, CT (SLC22A6, OAT1, PAHT, Solute carrier family 22 member 6, Organic anion transporter 1, PAH transporter, Renal organic anion transporter 1) (MaxLight 405) discontinued
Sign In for Pricing
View Details